- Selective small-molecule EPAC activators
Urszula Luchowska-Stańska et al, 2019, Biochemical Society Transactions CrossRef - The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
Junjie Zhao et al, 2022, Frontiers in Cell and Developmental Biology CrossRef - cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang et al, 2024, Journal of Hematology & Oncology CrossRef - Cancer – An ongoing fight searching for reasons and therapies
Susanne Ackermann et al, 2019, Acta Physiologica CrossRef - PDE4 and Epac1 Synergistically Promote Rectal Carcinoma via the cAMP Pathway
Xiangyu Kong et al, 2019, Analytical Cellular Pathology CrossRef - Chemical synthesis and biological activity of novel brominated 7-deazaadenosine-3′,5′-cyclic monophosphate derivatives
Marco Lelle et al, 2019, Bioorganic & Medicinal Chemistry CrossRef - The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation
Graeme Barker et al, 2017, Journal of Cardiovascular Development and Disease CrossRef - cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
Muhammad Bilal Ahmed et al, 2022, Cells CrossRef - The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells
Zhengyin Gao et al, 2022, Molecules CrossRef - Epac as a tractable therapeutic target
Hasan Slika et al, 2023, European Journal of Pharmacology CrossRef - EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer
Zishuo Li et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef - Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
William G. Robichaux et al, 2018, Physiological Reviews CrossRef - Stability, pharmacokinetics, and biodistribution in mice of the EPAC1 inhibitor (R)-CE3F4 entrapped in liposomes and lipid nanocapsules
Balthazar Toussaint et al, 2021, International Journal of Pharmaceutics CrossRef - Loss of cyclin‐dependent kinase‐like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion
Chia‐Lang Fang et al, 2018, Cancer Medicine CrossRef - Creating a potential diagnostic for prostate cancer risk stratification (InformMDx™) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7)
Dave J.P. Henderson et al, 2019, Clinical Science CrossRef - Function of m 5 C RNA methyltransferase NOP2 in high-grade serous ovarian cancer
Shimin Yang et al, 2023, Cancer Biology & Therapy CrossRef - Epac, a positive or negative signaling molecule in cardiovascular diseases
Yu-Qing Tan et al, 2022, Biomedicine & Pharmacotherapy CrossRef - Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
Yunfeng Pan et al, 2022, Frontiers in Pharmacology CrossRef - Ubiquitin‐specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis
Chia‐Lang Fang et al, 2018, Cancer Science CrossRef - Gene expression profile analysis of ENO1 knockdown in gastric cancer cell line MGC‑803
Zhigang Huang et al, 2019, Oncology Letters CrossRef - The Role of Epac in Cancer Progression
Nadine Wehbe et al, 2020, International Journal of Molecular Sciences CrossRef - Interspecies comparison of plasma metabolism and sample stabilization for quantitative bioanalyses: Application to (R)-CE3F4 in preclinical development, including metabolite identification by high-resolution mass spectrometry
Balthazar Toussaint et al, 2021, Journal of Chromatography B CrossRef - EPAC Regulates Melanoma Growth by Stimulating mTORC1 Signaling and Loss of EPAC Signaling Dependence Correlates with Melanoma Progression
Aishwarya Krishnan et al, 2022, Molecular Cancer Research CrossRef